New Inhibitor Targets Cancer’s Mitochondrial Glutamine Transporter
In a groundbreaking development poised to revolutionize cancer treatment paradigms, researchers have unveiled a novel therapeutic target that exploits the metabolic vulnerabilities of cancer cells....
















